查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2032385

心臟生物標記市場報告：按類型、檢測施行地點、應用和地區分類（2026-2034 年）

Cardiac Biomarkers Market Report by Type (Troponins, Myocardial Muscle Creatine Kinase, Myoglobin, Brain Natriuretic Peptide or NT-proBNP, Ischemia Modified Albumin, and Others), Location of Testing, Application, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 141 Pages | 商品交期: 2-3個工作天內

價格

2025年全球心臟生物標記市場規模達123億美元。展望未來，IMARC Group預測，從2026年到2034年，該市場將以7.15%的複合年成長率成長，到2034年達到233億美元。

心臟標記（也稱為心臟生物標記）在心臟承受壓力或心肌受損時會釋放到血液中。這些標記物包括多種酵素、荷爾蒙和蛋白質，例如心肌肌鈣蛋白、肌酸激酶 (CK)、缺血修飾白蛋白 (IMA) 和肌紅蛋白。測量和檢測這些標記有助於診斷心肌缺血和急性冠狀動脈症候群(ACS) 等心臟疾病。目前，用於確定這些疾病風險的分流和診斷系統主要基於心電圖 (ECG) 和病歷。然而，這些系統並不完善，可能導致誤診和延誤治療。心臟標記檢測因其高度準確性和能夠早期識別疾病而受到全球關注。這些標記也有助於更準確地監測疾病預後，並為患者提供最有效的治療。

全球心臟生物標記市場的主要促進因素：

近年來，急性冠狀動脈症候群（ACS）患者數量不斷增加，導致全球對心臟生物標記檢測的需求日益成長。此外，患者和醫療專業人員對早期診斷各種心血管疾病（CVD）重要性的認知不斷提高，也推動了對這些標記的需求。同時，許多公立和私立機構正加大研發投入，致力於開發心臟生物標記領域的先進技術。例如，高靈敏度心肌肌鈣蛋白I血液檢測已被證實能夠識別復發性心肌梗塞高風險患者。生物標記檢測的高準確性和快速出結果，以及價格合理的即時就地檢驗的普及，也是推動市場成長的因素。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球心臟生物標記市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場區隔：按類型
  • 市場區隔：依測試施行地點分類
  • 市場區隔：按應用領域
  • 市場區隔：按地區
  • 市場預測

第6章 市場區隔：依類型

  • 肌鈣蛋白（T 和 I）
  • 心肌肌酸激酶（CK-MB）
  • 肌紅蛋白
  • 腦鈉肽 (BNP) 或 NT-proBNP
  • 缺血修飾白蛋白（IMA）
  • 其他

第7章 市場區隔：依檢驗施行地點

  • 臨床試驗
  • 即時檢測

第8章 市場區隔：依應用領域分類

  • 心肌梗塞
  • 鬱血性心臟衰竭
  • 急性冠狀動脈症候群
  • 動脈粥狀硬化
  • 其他

第9章 市場區隔：依地區分類

  • 北美洲
  • 亞太地區
  • 歐洲
  • 中東和非洲
  • 拉丁美洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Abbott Laboratories
    • Alere Inc.
    • Beckman Coulter
    • Becton, Dickinson And Co.
    • Biomerieux
    • Bio-Rad Laboratories
    • Randox Laboratories
    • Roche Diagnostics Corporation
    • Siemens Healthcare
    • Thermo Fisher Scientific
Product Code: SR112026A1178

The global cardiac biomarkers market size reached USD 12.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 23.3 Billion by 2034, exhibiting a growth rate (CAGR) of 7.15% during 2026-2034.

Cardiac markers, also known as cardiac biomarkers, are released into the bloodstream when the heart is stressed, or its muscles are damaged. These markers include different types of enzymes, hormones, and proteins, such as cardiac troponins, creatine kinase (CK), ischemia-modified albumin (IMA), and myoglobin. Measurement and testing of these markers can help in diagnosing heart conditions like cardiac ischemia and acute coronary syndrome (ACS) . At present, the triage and diagnostic systems used for determining the risk of these conditions are based on electrocardiograms (ECGs) and clinical history. However, these systems are insufficient and can lead to misdiagnosis or delay in treatment. As cardiac marker testing offers higher accuracy and can identify the conditions in the early stages of presentation, they are gaining traction across the globe. These markers can also help in monitoring the prognosis of these condition with greater accuracy and providing the most effective treatment to the patients.

GLOBAL CARDIAC BIOMARKERS MARKET DRIVERS:

Over the past few years, there has been a rise in the number of patients suffering from ACS which has created a demand for cardiac marker testing at a global level. Other than this, rising awareness among patients and healthcare providers about the importance of early diagnosis of various CVDs is driving the demand for these markers. In addition, there are numerous private and public organizations which are investing in R&D activities to develop advanced technologies in the field of cardiac biomarkers. For instance, blood tests for high-sensitivity cardiac troponin I have been demonstrated to identify patients who are at a higher risk of a second heart attack. Moreover, high accuracy and rapid results offered by biomarker testing, coupled with the availability of affordable cardiac point-of-care testing, are some of the other factors which are contributing to the growth of the market.

KEY MARKET SEGMENTATION:

Breakup by Type:

  • Troponins (T and I)
  • Myocardial Muscle Creatine Kinase (CK-MB)
  • Myoglobin
  • Brain Natriuretic Peptide (BNPs) or NT-proBNP
  • Ischemia Modified Albumin (IMA)
  • Others

Based on the type, the market has been segmented into troponins (T and I), myocardial muscle creatine kinase (CK-MB), myoglobin, brain natriuretic peptide (BNPs) or NT-proBNP, ischemia modified albumin (IMA) and others. Breakup by Location of Testing:

  • Laboratory Testing
  • Point of Care Testing

Based on the location of testing, the market has been segmented into laboratory testing and point of care testing. Laboratory testing currently accounts for a larger share.

Breakup by Application:

  • Myocardial Infarction
  • Congestive Heart Failure
  • Acute Coronary Syndrome
  • Atherosclerosis
  • Others

Based on the application, the market has been segmented into myocardial infarction, congestive heart failure, acute coronary syndrome, atherosclerosis and others. Myocardial infarction currently accounts for the highest share.

Regional Insights:

  • North America
  • Asia Pacific
  • Europe
  • Middle East and Africa
  • Latin America

Region-wise, the market has been segmented into North America, Asia Pacific, Europe, Middle East and Africa, and Latin America. Amongst these, North America is the biggest market, accounting for majority of the global share.

COMPETITIVE LANDSCAPE:

The report has also analyzed the competitive landscape of the market with some of the key players being Abbott Laboratories, Alere Inc., Beckman Coulter, Becton, Dickinson And Co., Biomerieux, Bio-Rad Laboratories, Randox Laboratories, Roche Diagnostics Corporation, Siemens Healthcare and Thermo Fisher Scientific.

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cardiac Biomarkers Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Type
  • 5.5 Market Breakup by Location of Testing
  • 5.6 Market Breakup by Application
  • 5.7 Market Breakup by Region
  • 5.8 Market Forecast

6 Market Breakup by Type

  • 6.1 Troponins (T and I)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Myocardial Muscle Creatine Kinase (CK-MB)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Myoglobin
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Brain Natriuretic Peptide (BNPs) or NT-proBNP
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Ischemia Modified Albumin (IMA)
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Location of Testing

  • 7.1 Laboratory Testing
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Point of Care Testing
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Myocardial Infarction
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Congestive Heart Failure
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Acute Coronary Syndrome
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Atherosclerosis
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Middle East and Africa
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Latin America
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Global Cardiac Biomarkers Industry: SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Global Cardiac Biomarkers Industry: Value Chain Analysis

12 Global Cardiac Biomarkers Industry: Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Global Cardiac Biomarkers Industry: Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
    • 14.3.2 Alere Inc.
    • 14.3.3 Beckman Coulter
    • 14.3.4 Becton, Dickinson And Co.
    • 14.3.5 Biomerieux
    • 14.3.6 Bio-Rad Laboratories
    • 14.3.7 Randox Laboratories
    • 14.3.8 Roche Diagnostics Corporation
    • 14.3.9 Siemens Healthcare
    • 14.3.10 Thermo Fisher Scientific

List of Figures

  • Figure 1: Global: Cardiac Biomarkers Market: Major Drivers and Challenges
  • Figure 2: Global: Cardiac Biomarkers Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Cardiac Biomarkers Market: Breakup by Type (in %), 2025
  • Figure 4: Global: Cardiac Biomarkers Market: Breakup by Location of Testing (in %), 2025
  • Figure 5: Global: Cardiac Biomarkers Market: Breakup by Application (in %), 2025
  • Figure 6: Global: Cardiac Biomarkers Market: Breakup by Region (in %), 2025
  • Figure 7: Global: Cardiac Biomarkers Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 8: Global: Cardiac Biomarkers Industry: SWOT Analysis
  • Figure 9: Global: Cardiac Biomarkers Industry: Value Chain Analysis
  • Figure 10: Global: Cardiac Biomarkers Industry: Porter's Five Forces Analysis
  • Figure 11: Global: Cardiac Biomarkers (Troponins) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Cardiac Biomarkers (Troponins) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Cardiac Biomarkers (Myocardial Muscle Creatine Kinase) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Cardiac Biomarkers (Myocardial Muscle Creatine Kinase) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Cardiac Biomarkers (Myoglobin) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Cardiac Biomarkers (Myoglobin) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Cardiac Biomarkers (Brain Natriuretic Peptide) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Cardiac Biomarkers (Brain Natriuretic Peptide) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Cardiac Biomarkers (Ischemia Modified Albumin) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Cardiac Biomarkers (Ischemia Modified Albumin) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Cardiac Biomarkers (Other Types) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Cardiac Biomarkers (Other Types) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Cardiac Biomarkers (Laboratory Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Cardiac Biomarkers (Laboratory Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Cardiac Biomarkers (Point of Care Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Cardiac Biomarkers (Point of Care Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Cardiac Biomarkers (Myocardial Infarction) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Cardiac Biomarkers (Myocardial Infarction) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Cardiac Biomarkers (Congestive Heart Failure) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Cardiac Biomarkers (Congestive Heart Failure) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Global: Cardiac Biomarkers (Acute Coronary Syndrome) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Global: Cardiac Biomarkers (Acute Coronary Syndrome) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Global: Cardiac Biomarkers (Atherosclerosis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Global: Cardiac Biomarkers (Atherosclerosis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Global: Cardiac Biomarkers (Other Applications) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Global: Cardiac Biomarkers (Other Applications) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: North America: Cardiac Biomarkers Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: North America: Cardiac Biomarkers Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Asia Pacific: Cardiac Biomarkers Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Asia Pacific: Cardiac Biomarkers Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Europe: Cardiac Biomarkers Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Europe: Cardiac Biomarkers Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Middle East and Africa: Cardiac Biomarkers Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Middle East and Africa: Cardiac Biomarkers Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: Latin America: Cardiac Biomarkers Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: Latin America: Cardiac Biomarkers Market Forecast: Sales Value (in Million USD), 2026-2034

List of Tables

  • Table 1: Global: Cardiac Biomarkers Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Cardiac Biomarkers Market Forecast: Breakup by Type (in Million USD), 2026-2034
  • Table 3: Global: Cardiac Biomarkers Market Forecast: Breakup by Location of Testing (in Million USD), 2026-2034
  • Table 4: Global: Cardiac Biomarkers Market Forecast: Breakup by Application (in Million USD), 2026-2034
  • Table 5: Global: Cardiac Biomarkers Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Cardiac Biomarkers Market Structure
  • Table 7: Global: Cardiac Biomarkers Market: Key Players